{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:52Z","timestamp":1761182992148,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jiac.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T17:48:22Z","timestamp":1598032102000},"page":"1129-1133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors affecting the failure to complete treatment for patients with latent tuberculosis infection in Tokyo, Japan"],"prefix":"10.1016","volume":"26","author":[{"given":"Yoshiyuki","family":"Sugishita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamae","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamie","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ohkusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-6","key":"10.1016\/j.jiac.2020.05.007_bib1","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"year":"2019","series-title":"Global tuberculosis report 2019","key":"10.1016\/j.jiac.2020.05.007_bib2"},{"issue":"6","key":"10.1016\/j.jiac.2020.05.007_bib3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"year":"2014","series-title":"The End TB Strategy, Global strategy and targets for tuberculosis prevention, care and control after 2015","key":"10.1016\/j.jiac.2020.05.007_bib4"},{"issue":"12","key":"10.1016\/j.jiac.2020.05.007_bib5","first-page":"231","article-title":"Tuberculosis in Japan, 2016","volume":"38","year":"2017","journal-title":"Infect Agents Surveillance Rep"},{"issue":"9","key":"10.1016\/j.jiac.2020.05.007_bib6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.5588\/ijtld.12.0823","article-title":"Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection?","volume":"17","author":"Hirsch-Moverman","year":"2013","journal-title":"Int J Tubercul Lung Dis"},{"issue":"5","key":"10.1016\/j.jiac.2020.05.007_bib7","first-page":"941","article-title":"Latent tuberculosis infection: screening and treatment in an urban setting","volume":"38","author":"Morano","year":"2013","journal-title":"J\u00a0Community Health"},{"issue":"1","key":"10.1016\/j.jiac.2020.05.007_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0163278702250080","article-title":"Assessment of tuberculosis treatment completion in an ethnically diverse population using two data sources. Implications for treatment interventions","volume":"26","author":"Morisky","year":"2003","journal-title":"Eval Health Prof"},{"issue":"4","key":"10.1016\/j.jiac.2020.05.007_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"10.1016\/j.jiac.2020.05.007_bib10","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"Page","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.jiac.2020.05.007_bib11","first-page":"262","article-title":"Predictors of failure to complete treatment for latent tuberculosis infection","volume":"54","author":"Parsyan","year":"2007","journal-title":"J\u00a0Infect"},{"issue":"11","key":"10.1016\/j.jiac.2020.05.007_bib12","doi-asserted-by":"crossref","first-page":"e0186588","DOI":"10.1371\/journal.pone.0186588","article-title":"Trend and treatment status of latent tuberculosis infection patients in Japan - analysis of Japan TB Surveillance data","volume":"12","author":"Kawatsu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jiac.2020.05.007_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1378\/chest.07-2024","article-title":"Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island","volume":"133","author":"Kwara","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jiac.2020.05.007_bib14","first-page":"507","article-title":"Evaluation for treatment results and DOTS in latent tuberculosis infection","volume":"90","author":"Kasai","year":"2015","journal-title":"Kekkaku"},{"first-page":"7","year":"2014","series-title":"Ethical Guidelines for Medical and Health Research Involving Human Subjects, 22 December, 2014","key":"10.1016\/j.jiac.2020.05.007_bib15"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2030163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2030163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:29Z","timestamp":1761159629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2030163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1341321X2030163X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.05.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors affecting the failure to complete treatment for patients with latent tuberculosis infection in Tokyo, Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}